Your browser doesn't support javascript.
loading
Thrombin formation via the intrinsic coagulation pathway and von Willebrand factor reflect disease severity in COVID-19.
Busch, Matthias H; Timmermans, Sjoerd A M E G; Van Kuijk, Sander M J; Aendekerk, Joop P; Ysermans, Renée; Van Doorn, Daan P C; Potjewijd, Judith; Van de Poll, Marcel C G; Van der Horst, Iwan C C; Damoiseaux, Jan G M C; Spronk, Henri M H; Cate, Hugo Ten; Reutelingsperger, Chris P; Nagy, Magdolna; Van Paassen, Pieter.
Afiliação
  • Busch MH; Dept. Nephrology and Clinical Immunology, Maastricht University Medical Center, Maastricht, the Netherlands; Dept. Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht.
  • Timmermans SAMEG; Dept. Nephrology and Clinical Immunology, Maastricht University Medical Center, Maastricht, the Netherlands; Dept. Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht.
  • Van Kuijk SMJ; Dept. of Clinical Epidemiology and Medical Technology Assessment.
  • Aendekerk JP; Dept. Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht.
  • Ysermans R; Dept. Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht.
  • Van Doorn DPC; Dept. Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht.
  • Potjewijd J; Dept. Nephrology and Clinical Immunology, Maastricht University Medical Center, Maastricht, the Netherlands; Dept. Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht.
  • Van de Poll MCG; Dept. Intensive Care Medicine.
  • Van der Horst ICC; Dept. Intensive Care Medicine.
  • Damoiseaux JGMC; Central Diagnostic Laboratory.
  • Spronk HMH; Dept. Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht, the Netherlands; Thrombosis Expertise Center, Maastricht University Medical Center, Maastricht.
  • Cate HT; Dept. Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht, the Netherlands; Thrombosis Expertise Center, Maastricht University Medical Center, Maastricht.
  • Reutelingsperger CP; Dept. Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht.
  • Nagy M; Dept. Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht.
  • Van Paassen P; Dept. Nephrology and Clinical Immunology, Maastricht University Medical Center, Maastricht, the Netherlands; Dept. Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht. p.vanpaassen@maastrichtuniversity.nl.
Haematologica ; 108(5): 1417-1422, 2023 05 01.
Article em En | MEDLINE | ID: mdl-36519327
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças de von Willebrand / COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças de von Willebrand / COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article